| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |